{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:11:21Z","timestamp":1788790281370,"version":"build-2803163510"},"reference-count":33,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Arginine vasopressin deficiency (AVP\u2010D) requires lifelong desmopressin replacement. In March 2025, the national suspension of intranasal desmopressin necessitated urgent transition to oral alternatives. However, optimal conversion ratios and clinical response remain undefined. We evaluated clinical outcomes following this supply\u2010driven transition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study at a tertiary UK centre (01\/01\/2025\u201301\/07\/2025) identified patients with confirmed AVP\u2010D switched from intranasal to oral desmopressin. Demographic and clinical data were collected. Conversion ratios (intranasal: oral) were calculated before and after titration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty two patients were included (mean age 52.6\u2009\u00b1\u20092.3; 31% male). 15\/42 (35.7%) isolated AVP\u2010D; 11\/42 (26.2%) partial hypopituitarism; 16\/42 (38.1%) panhypopituitarism. Median intranasal desmopressin dose pre\u2010switch was 10\u2009mcg\/day (IQR 10\u201320\u2009mcg). Initial median oral dose before titration was 200\u2009mcg\/day (IQR 100\u2013200\u2009mcg); final median oral dose after titration was 200\u2009mcg\/day (IQR 162.5\u2013300\u2009mcg). 23\/42 (54.8%) were switched initially using 1:10 ratio (10\u2009mcg intranasal desmopressin to 100\u2009mcg oral tablet). 13\/23 (56.5%) reported symptomatic recurrence, warranting further titration. The remaining 19\/42 (45.2%) were switched initially using a median ratio of 1:20 (IQR 1:11.8\u20131:20). 10\/19 (52.6%) reported symptomatic recurrence. Overall, switching from intranasal to oral desmopressin resulted in 16 patient calls, 79 additional blood tests and one hospitalisation. Similarly, the findings of The Pituitary Foundation Impact Report demonstrated that the switch led to 121\/161 (75.2%) of patients reporting poorer symptomatic control post\u2010switch, and 76\/161 (47.2%) requiring additional endocrine input.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>45.2% (19\/42) of patients achieved adequate symptom control post\u2010switch with varying conversion ratios, and over half (13\/23, 56.5%) of patients switched with an initial 1:10 conversion ratio reported symptomatic recurrence. Although a higher initial conversion ratio closer to 1:15 may reduce symptomatic recurrence in some patients, initiating treatment at a 1:10 ratio with careful up\u2010titration represents a safe and pragmatic approach that minimises the risk of over\u2010replacement and hyponatraemia, although inter\u2010patient variability necessitates tailored titration. In parallel, national patient\u2010reported data from The Pituitary Foundation Impact Report demonstrate the substantial patient and clinical burden of this supply\u2010driven switch, highlighting the need for standardised guidance and prospective studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cen.70120","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:50:44Z","timestamp":1773373844000},"page":"66-76","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Outcomes Following Supply\u2010Driven Transition From Intranasal to Oral Desmopressin in AVP\u2010Deficiency\u2014A Single Centre Experience Including The Pituitary Foundation Desmopressin Shortage Impact Report"],"prefix":"10.1111","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8254-5942","authenticated-orcid":false,"given":"Trevor","family":"Tam","sequence":"first","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"},{"name":"University of East Anglia Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Mach","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alam","family":"Wahid","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetha","family":"Joseph","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Shingler","sequence":"additional","affiliation":[{"name":"The Pituitary Foundation Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"McBride","sequence":"additional","affiliation":[{"name":"The Pituitary Foundation Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Swords","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Dhatariya","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"},{"name":"University of East Anglia Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6885-0875","authenticated-orcid":false,"given":"Rupa","family":"Ahluwalia","sequence":"additional","affiliation":[{"name":"Norfolk and Norwich University Hospital Norwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,3,12]]},"reference":[{"key":"e_1_2_12_2_1","unstructured":"Arginine Vasopressin Deficiency (Diabetes Insipidus). Society for Endocrinology n.d. accessed August 13 2025 https:\/\/www.endocrinology.org\/clinical-practice\/clinical-guidance\/arginine-vasopressin-deficiency-diabetes-insipidus\/."},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac381"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-024-00985-x"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.37349\/emed.2025.1001289"},{"key":"e_1_2_12_6_1","unstructured":"Desmopressin Nasal Spray Out of stock until September 2025 Sf E n.d. accessed August 13 2025 https:\/\/www.endocrinology.org\/news\/item\/23284\/desmopressin-nasal-spray-out-of-stock-until-september-2025?."},{"key":"e_1_2_12_7_1","first-page":"189","article-title":"[Long\u2010Term Treatment of Central Diabetes Insipidus With Oral DDAVP]","volume":"17","author":"Carraro A.","year":"1992","journal-title":"Minerva Endocrinologica"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ14-0368"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ13-0165"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12498"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JURO.2007.03.015"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-2198-7207"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-024-01454-4"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1157"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181577511"},{"key":"e_1_2_12_16_1","unstructured":"C.FdaCSL Behring LLC Stimate \u00ae Package Insert (desmopressin acetate) n.d."},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2021.100082"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2016.02.007"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-015-0637-3"},{"key":"e_1_2_12_20_1","unstructured":"Peroral treatment of diabetes insipidus with a polypeptide hormone analog desmopressin. PubMed n.d. accessed August 10 2025 https:\/\/pubmed.ncbi.nlm.nih.gov\/4032289\/."},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.62.7.674"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2024.12592"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002930"},{"key":"e_1_2_12_24_1","unstructured":"[Treatment of diabetes insipidus with Minirin. Switch From Nasal to Oral Administration] \u2010 PubMed n.d. accessed August 10 2025 https:\/\/pubmed.ncbi.nlm.nih.gov\/9949892\/."},{"key":"e_1_2_12_25_1","unstructured":"Drugs FDA n.d. accessed August 10 2025 https:\/\/www.fda.gov\/drugs."},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ14-0097"},{"key":"e_1_2_12_27_1","first-page":"155","article-title":"Comparison of Desmopressin (DDAVP) Tablet and Intranasal Spray in the Treatment of Central Diabetes Insipidus","volume":"13","author":"Larijani B.","year":"2005","journal-title":"DARU Journal of Pharmaceutical Sciences"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.13718"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2015.04.013"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.3401166.x"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.5414\/CPP44172"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.61.3.247"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09862-w"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-14-0719"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.70120","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cen.70120","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cen.70120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T13:15:58Z","timestamp":1788786958000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cen.70120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/cen.70120"],"URL":"https:\/\/doi.org\/10.1111\/cen.70120","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,12]]},"assertion":[{"value":"2025-11-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}